Brad leads projects to deliver real world evidence solutions, medical and market access strategy for the pharmaceutical industry and its stakeholders. Brad has almost 20 years of experience in the Life Sciences industry across government and private sectors in Canada and globally. His interests include developing innovative approaches to leveraging “big” healthcare datasets to answer core questions about value and outcomes in the healthcare system.
Prior to joining IQVIA, he led the investment attraction function for Life Sciences at the Department of Foreign Affairs and International Trade. He also spent several years in the US at a leading biotech strategy consulting firm developing solutions in new product development & launch, marketing, sales, and business development. He is a Dean’s List graduate of the MBS program (integrated MSc Biotech + MBA ) at Keck Graduate Institute in Claremont, California, and holds a B.Sc. in Physiology from McGill University.
Brad speaks English and French, and is conversational in Mandarin Chinese